Parliamentary Search

Written question asked by Bradley Thomas (Conservative) on Thursday, 4 June 2026, in the House of Commons. It was due for an answer on Monday, 8 June 2026. It was answered by Preet Kaur Gill (Labour) on Tuesday, 16 June 2026 on behalf of the Department of Health and Social Care.

ADHD: Drugs

Question

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of waiting times for ADHD medication reviews in Bromsgrove constituency; what steps he is taking to reduce those waiting times to ensure patients are not left on the wrong dosage for prolonged periods; and what plans he has to streamline ADHD diagnosis and medication review processes.

Answer

It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including provision of attention deficit hyperactivity disorder (ADHD) services.

In respect of ADHD, the National Institute for Health and Care Excellence guideline does not set out a timeframe within which medication should be provided or reviewed, but it does say that children, young people, and adults receiving treatment for ADHD have reviews and follow-ups according to the severity of their condition, regardless of whether or not they are taking medication.

The NHS Herefordshire and Worcestershire ICB has taken direct action on medication reviews for ADHD. It has commissioned reviewing capacity from both local general practice federations to undertake medication reviews for adults. It has commissioned additional nurse prescribing capacity in the local trust for children, to ensure that medication is initiated in a timely way and that reviews are undertaken at the required frequency.

Additionally, NHS Herefordshire and Worcestershire have agreed pathways for adults and children which blend the use of Right to Choose, National Health Service trusts, and commissioned independent providers, all designed to improve outcomes and experiences and to maximise efficiency. This will be enhanced with the introduction of a new commissioning policy in the summer.

Secondary information

Type
Written question
Reference
6924
Session
2026-27
Subjects
Drugs ADHD Waiting lists Bromsgrove
Link
View this Written question on www.parliament.uk